Page 2 - Daniel Mackey News Today

The city on Wednesday began moving hundreds of people out of “the Zone,” spread over several blocks downtown, but some homeless people worry about where they will go.

Cork-based software company targets further growth in the US, where it has recently opened a new office

Cork-based co-working hub benefiting from companies looking at hybrid options for staff

Cork-based software company posts 10.3% rise in turnover to $29.5m for 2020

This cookie cutter rom-com has nothing more or less than what its subgenre demands.

CORBIN - The Corbin Tourism Commission approved increasing its Christmas decoration budget by $10,000 during a special-called meeting Wednesday.

A distant photo of the retirement party, published with permission from a local resident who drove past the event. At least six Southold Town Police Department employees are being questioned in an ongoing probe of the department’s response to community complaints about a sergeant’s retirement party last May, according to billing records filed with the town. As of Feb. 23, a police sergeant, one police officer and two dispatchers had been deposed by outside counsel hir...

Infant Bacterial Therapeutics AB: Infant Bacterial Therapeutics CFO leaves the company Infant Bacterial Therapeutics ABs CFO Daniel Mackey has decided to leave the company to pursue new challenges. He will remain in his current role during his notice period. Michael Owens will be acting CFO when Daniel leaves the company and until his replacement is in place. The recruitment process has already been initiated. "I would like to take this opportunity to thank Daniel and wish him every success in ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Infant Bacterial Therapeutics AB: Annual General Meeting of Infant Bacterial Therapeutics CEO speech About Infant Bacterial Therapeutics AB Infant Bacterial Therapeutics AB (publ) is a pharmaceutical company with a product in Phase III with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants. IBT is currently developing the drug candidate IBP-9414, for the prevention of necrotizing enterocolitis ("NEC") and improvement of fee...